Selected research
Market Structure
Global Beta-2 Microglobulin (B2M) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Beta-2 Microglobulin (B2M) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Beta-2 Microglobulin (B2M) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Beta-2 Microglobulin (B2M) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Beta-2 Microglobulin (B2M) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Beta-2 Microglobulin (B2M) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Beta-2 Microglobulin (B2M) include Wuhan Huamei Biotech Co, Fosun Pharmaceutical, Tosoh, Prospec-Tany Technogene Ltd, Lee Biosolutions, Bio-Rad and Abcam, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Beta-2 Microglobulin (B2M) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Beta-2 Microglobulin (B2M) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Beta-2 Microglobulin (B2M) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Beta-2 Microglobulin (B2M) market size, projected growth trends, production technologies, key applications, and end-use industries.
Beta-2 Microglobulin (B2M) Segment by Company
Wuhan Huamei Biotech Co
Fosun Pharmaceutical
Tosoh
Prospec-Tany Technogene Ltd
Lee Biosolutions
Bio-Rad
Abcam
Beta-2 Microglobulin (B2M) Segment by Type
Purity,≥98%
Purity,≥95%
Others
Beta-2 Microglobulin (B2M) Segment by Application
ELISA
Flow Cytometry
Western Blotting
Others
Beta-2 Microglobulin (B2M) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Beta-2 Microglobulin (B2M) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Beta-2 Microglobulin (B2M) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Beta-2 Microglobulin (B2M).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Beta-2 Microglobulin (B2M) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Beta-2 Microglobulin (B2M) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Beta-2 Microglobulin (B2M) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Beta-2 Microglobulin (B2M) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Purity,≥98%
- Purity,≥95%
- Others
Applications
- ELISA
- Flow Cytometry
- Western Blotting
- Others
Companies covered
- Wuhan Huamei Biotech Co
- Fosun Pharmaceutical
- Tosoh
- Prospec-Tany Technogene Ltd
- Lee Biosolutions
- Bio-Rad
- Abcam
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Beta-2 Microglobulin (B2M) Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Beta-2 Microglobulin (B2M) Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Beta-2 Microglobulin (B2M) Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Beta-2 Microglobulin (B2M) Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Beta-2 Microglobulin (B2M) Market Dynamics
- 2.1 Beta-2 Microglobulin (B2M) Industry Trends
- 2.2 Beta-2 Microglobulin (B2M) Industry Drivers
- 2.3 Beta-2 Microglobulin (B2M) Industry Opportunities and Challenges
- 2.4 Beta-2 Microglobulin (B2M) Industry Restraints
3 Beta-2 Microglobulin (B2M) Market by Manufacturers
- 3.1 Global Beta-2 Microglobulin (B2M) Revenue by Manufacturers (2021-2026)
- 3.2 Global Beta-2 Microglobulin (B2M) Sales by Manufacturers (2021-2026)
- 3.3 Global Beta-2 Microglobulin (B2M) Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Beta-2 Microglobulin (B2M) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Beta-2 Microglobulin (B2M) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Beta-2 Microglobulin (B2M) Manufacturers, Product Type & Application
- 3.7 Global Beta-2 Microglobulin (B2M) Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Beta-2 Microglobulin (B2M) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Beta-2 Microglobulin (B2M) Players Market Share by Revenue in 2025
- 3.8.3 2025 Beta-2 Microglobulin (B2M) Tier 1, Tier 2, and Tier 3
4 Beta-2 Microglobulin (B2M) Market by Type
- 4.1 Beta-2 Microglobulin (B2M) Type Introduction
- 4.1.1 Purity,≥98%
- 4.1.2 Purity,≥95%
- 4.1.3 Others
- 4.2 Global Beta-2 Microglobulin (B2M) Sales by Type
- 4.2.1 Global Beta-2 Microglobulin (B2M) Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Beta-2 Microglobulin (B2M) Sales by Type (2021-2032)
- 4.2.3 Global Beta-2 Microglobulin (B2M) Sales Market Share by Type (2021-2032)
- 4.3 Global Beta-2 Microglobulin (B2M) Revenue by Type
- 4.3.1 Global Beta-2 Microglobulin (B2M) Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Beta-2 Microglobulin (B2M) Revenue by Type (2021-2032)
- 4.3.3 Global Beta-2 Microglobulin (B2M) Revenue Market Share by Type (2021-2032)
5 Beta-2 Microglobulin (B2M) Market by Application
- 5.1 Beta-2 Microglobulin (B2M) Application Introduction
- 5.1.1 ELISA
- 5.1.2 Flow Cytometry
- 5.1.3 Western Blotting
- 5.1.4 Others
- 5.2 Global Beta-2 Microglobulin (B2M) Sales by Application
- 5.2.1 Global Beta-2 Microglobulin (B2M) Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Beta-2 Microglobulin (B2M) Sales by Application (2021-2032)
- 5.2.3 Global Beta-2 Microglobulin (B2M) Sales Market Share by Application (2021-2032)
- 5.3 Global Beta-2 Microglobulin (B2M) Revenue by Application
- 5.3.1 Global Beta-2 Microglobulin (B2M) Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Beta-2 Microglobulin (B2M) Revenue by Application (2021-2032)
- 5.3.3 Global Beta-2 Microglobulin (B2M) Revenue Market Share by Application (2021-2032)
6 Global Beta-2 Microglobulin (B2M) Sales by Region
- 6.1 Global Beta-2 Microglobulin (B2M) Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Beta-2 Microglobulin (B2M) Sales by Region (2021-2032)
- 6.2.1 Global Beta-2 Microglobulin (B2M) Sales by Region (2021-2026)
- 6.2.2 Global Beta-2 Microglobulin (B2M) Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Beta-2 Microglobulin (B2M) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Beta-2 Microglobulin (B2M) Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Beta-2 Microglobulin (B2M) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Beta-2 Microglobulin (B2M) Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Beta-2 Microglobulin (B2M) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Beta-2 Microglobulin (B2M) Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Beta-2 Microglobulin (B2M) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Beta-2 Microglobulin (B2M) Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Beta-2 Microglobulin (B2M) Revenue by Region
- 7.1 Global Beta-2 Microglobulin (B2M) Revenue by Region
- 7.1.1 Global Beta-2 Microglobulin (B2M) Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Beta-2 Microglobulin (B2M) Revenue by Region (2021-2026)
- 7.1.3 Global Beta-2 Microglobulin (B2M) Revenue by Region (2027-2032)
- 7.1.4 Global Beta-2 Microglobulin (B2M) Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Beta-2 Microglobulin (B2M) Revenue (2021-2032)
- 7.2.2 North America Beta-2 Microglobulin (B2M) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Beta-2 Microglobulin (B2M) Revenue (2021-2032)
- 7.3.2 Europe Beta-2 Microglobulin (B2M) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Beta-2 Microglobulin (B2M) Revenue (2021-2032)
- 7.4.2 Asia-Pacific Beta-2 Microglobulin (B2M) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Beta-2 Microglobulin (B2M) Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Beta-2 Microglobulin (B2M) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Wuhan Huamei Biotech Co
- 8.1.1 Wuhan Huamei Biotech Co Company Information
- 8.1.2 Wuhan Huamei Biotech Co Business Overview
- 8.1.3 Wuhan Huamei Biotech Co Beta-2 Microglobulin (B2M) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Wuhan Huamei Biotech Co Beta-2 Microglobulin (B2M) Product Portfolio
- 8.1.5 Wuhan Huamei Biotech Co Recent Developments
- 8.2 Fosun Pharmaceutical
- 8.2.1 Fosun Pharmaceutical Company Information
- 8.2.2 Fosun Pharmaceutical Business Overview
- 8.2.3 Fosun Pharmaceutical Beta-2 Microglobulin (B2M) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Fosun Pharmaceutical Beta-2 Microglobulin (B2M) Product Portfolio
- 8.2.5 Fosun Pharmaceutical Recent Developments
- 8.3 Tosoh
- 8.3.1 Tosoh Company Information
- 8.3.2 Tosoh Business Overview
- 8.3.3 Tosoh Beta-2 Microglobulin (B2M) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Tosoh Beta-2 Microglobulin (B2M) Product Portfolio
- 8.3.5 Tosoh Recent Developments
- 8.4 Prospec-Tany Technogene Ltd
- 8.4.1 Prospec-Tany Technogene Ltd Company Information
- 8.4.2 Prospec-Tany Technogene Ltd Business Overview
- 8.4.3 Prospec-Tany Technogene Ltd Beta-2 Microglobulin (B2M) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Prospec-Tany Technogene Ltd Beta-2 Microglobulin (B2M) Product Portfolio
- 8.4.5 Prospec-Tany Technogene Ltd Recent Developments
- 8.5 Lee Biosolutions
- 8.5.1 Lee Biosolutions Company Information
- 8.5.2 Lee Biosolutions Business Overview
- 8.5.3 Lee Biosolutions Beta-2 Microglobulin (B2M) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Lee Biosolutions Beta-2 Microglobulin (B2M) Product Portfolio
- 8.5.5 Lee Biosolutions Recent Developments
- 8.6 Bio-Rad
- 8.6.1 Bio-Rad Company Information
- 8.6.2 Bio-Rad Business Overview
- 8.6.3 Bio-Rad Beta-2 Microglobulin (B2M) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Bio-Rad Beta-2 Microglobulin (B2M) Product Portfolio
- 8.6.5 Bio-Rad Recent Developments
- 8.7 Abcam
- 8.7.1 Abcam Company Information
- 8.7.2 Abcam Business Overview
- 8.7.3 Abcam Beta-2 Microglobulin (B2M) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Abcam Beta-2 Microglobulin (B2M) Product Portfolio
- 8.7.5 Abcam Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Beta-2 Microglobulin (B2M) Value Chain Analysis
- 9.1.1 Beta-2 Microglobulin (B2M) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Beta-2 Microglobulin (B2M) Production Mode & Process
- 9.2 Beta-2 Microglobulin (B2M) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Beta-2 Microglobulin (B2M) Distributors
- 9.2.3 Beta-2 Microglobulin (B2M) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst